Holen Sie sich die Stockscreener-App
2.39
3.46%
0.08
Handel nachbörslich:
2.39
Schlusskurs vom Vortag:
$2.31
Offen:
$2.35
24-Stunden-Volumen:
102.32K
Relative Volume:
0.60
Marktkapitalisierung:
$38.36M
Einnahmen:
$6.66M
Nettoeinkommen (Verlust:
$-25.52M
KGV:
-1.9752
EPS:
-1.21
Netto-Cashflow:
$-28.98M
1W Leistung:
+5.29%
1M Leistung:
-9.13%
6M Leistung:
-56.82%
1J Leistung:
-67.08%
1-Tages-Spanne:
$2.33
$2.465
1-Wochen-Bereich:
$2.20
$2.465
52-Wochen-Spanne:
$2.10
$14.20
Veru Inc Stock (VERU) Company Profile
Firmenname
Veru Inc
Sektor
Branche
Telefon
(312) 595-9123
Adresse
2916 N. MIAMI AVENUE, MIAMI, FL
Vergleichen Sie VERU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
2.39 | 37.08M | 6.66M | -25.52M | -28.98M | -1.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Outperform |
| 2023-06-07 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-04-13 | Eingeleitet | Jefferies | Buy |
| 2021-02-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-03-20 | Eingeleitet | Oppenheimer | Outperform |
| 2018-07-03 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Veru Inc Aktie (VERU) Neueste Nachrichten
Why Veru Inc. (FMW) stock trades below fair valueTrade Entry Report & Fast Entry High Yield Tips - ulpravda.ru
Is Veru Inc. stock attractive after correction2025 Macro Impact & Entry Point Confirmation Alerts - ulpravda.ru
ulpravda> 2026> How dovish Fed policy supports Veru Inc. (FMW) stockTake Profit & High Conviction Buy Zone Picks - ulpravda.ru
Why Veru Inc. (FMW) stock remains stableProfit Target & Low Risk High Reward Ideas - ulpravda.ru
Aug Drivers: Why Veru Inc. (FMW) stock remains stable2025 Stock Rankings & Risk Controlled Stock Alerts - ulpravda.ru
Veru prices 1.4M shares at $3.00 in underwritten public offering - MSN
About UsGreat American Insurance GroupSpecialty Property & Casualty Insurance - FinancialContent
Veru Inc.Common Stock (NQ: VERU - FinancialContent
Is Veru Inc. (FMW) stock prepared for digital transitionWeekly Market Report & Daily Entry Point Trade Alerts - ulpravda.ru
User | poteaudailynews.comVeru Inc.Common Stock (Nasdaq:VERU) Stock Quote - FinancialContent
What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now? - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next? - Defense World
Veru outlines 72-week Phase IIb PLATEAU study targeting obesity plateau population following FDA guidance - MSN
Veru Inc | 4: Statement of changes in beneficial ownership of securities-Director Hyun Grace - 富途牛牛
Veru Inc. (NASDAQ:VERU) Q4 2025 Earnings Call Transcript - Insider Monkey
Market Review: Can Veru Inc stock maintain growth trajectoryJuly 2025 Short Interest & Trade Opportunity Analysis Reports - moha.gov.vn
Veru Inc. Earnings Call: Lean Mass Wins, Losses Mount - TipRanks
Is Veru Inc. stock a buy in volatile markets2025 Market Outlook & Weekly Watchlist of Top Performers - Улправда
Will Veru Inc. stock outperform Nasdaq indexPortfolio Value Summary & Free Real-Time Market Sentiment Alerts - Улправда
MACD Signal: Why Veru Inc. stock remains resilientTrade Entry Summary & Short-Term High Return Ideas - moha.gov.vn
Veru (NASDAQ:VERU) Upgraded by Wall Street Zen to Hold Rating - Defense World
Will Veru Inc. (FMW) stock profit from fiscal stimulusDividend Hike & Accurate Trade Setup Notifications - Улправда
How Veru Inc. stock reacts to oil pricesMarket Sentiment Summary & Daily Stock Trend Reports - Улправда
Will Veru Inc. stock continue dividend increasesMarket Risk Report & Technical Confirmation Alerts - Улправда
Canaccord Genuity Initiates Coverage of Veru (VERU) with Buy Recommendation - Nasdaq
Veru Inc. (VERU): Canaccord Genuity Initiates Coverage with a $2 - GuruFocus
Oppenheimer reiterates Outperform rating on Veru stock as enobosarm advances By Investing.com - Investing.com Nigeria
Oppenheimer reiterates Outperform rating on Veru stock as enobosarm advances - Investing.com Nigeria
Veru shares clinical progress in obesity program, details 2025 results By Investing.com - Investing.com Nigeria
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges By GuruFocus - Investing.com Canada
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges - Yahoo Finance
Veru Q4 2025 Earnings Call Transcript - MarketBeat
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Veru Inc. (VERU) Releases Q4 2025 Earnings: Flat Revenue, EPS Beat Amid Profitability and Cash Pressure - Quiver Quantitative
VERU INC. SEC 10-K Report - TradingView — Track All Markets
VERU: Net loss of $22.7M in FY2025, no commercial revenue, and urgent need for new capital - TradingView — Track All Markets
Earnings call transcript: Veru Inc. Q4 2025 sees strategic shifts amid financial losses - Investing.com India
Veru Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Veru shares clinical progress in obesity program, details 2025 results - Investing.com
Veru Inc. Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - TradingView — Track All Markets
Veru Inc. (NASDAQ: VERU) furnishes press release with FY 2025 results - Stock Titan
Veru (VERU) Beats EPS Expectations Despite Cash Decline - GuruFocus
Veru Inc. Achieves FDA Regulatory Clarity for Enobosarm as a Combination Therapy for Obesity Following Positive Phase 2b Study Results - Quiver Quantitative
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - The Manila Times
Veru Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
A Look Ahead: Veru's Earnings Forecast - Sahm
Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings - Benzinga
VERU Earnings Preview: Recent $VERU Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Veru Inc. to Host Conference Call for Fiscal Year 2025 Financial Results and Business Update - Quiver Quantitative
Finanzdaten der Veru Inc-Aktie (VERU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veru Inc-Aktie (VERU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rankowitz Michael L | Director |
Feb 19 '25 |
Buy |
0.58 |
54,721 |
31,919 |
250,000 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):